Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Lotus Pharmaceutical Co Ltd

Mr. Petar Antonov Vazharov

CEO & Director

Ms. Eeling  Chan

Chief Financial Officer

Mr. Vamsi Kiran Kosaraju

Chief Operations Officer

Ms. Gwen  Hsieh

Chief Information Officer

Ms. Yu-Ying  Yang

Associate Director of Co-Operate Communication

Boon Chong Tan

Deputy General Manager

Mr. Edin  Buljubasic

Vice President

Yingming  Yue

Valerie  Lau

Chief Commercial Officer-APAC

Mr. Manish  Chawla

Vice President of Research and Development

1795's next earnings is on March 12, 2025 (After Market Close)

1795's latest dividend is 3.45992 TWD on July 5, 2023

Lotus Pharmaceutical Co Ltd (1795) Stock Analysis, Discussion Forum and Financial Metrics - TWSE Exchange

Lotus Pharmaceutical Co Ltd (1795) Earnings Report Date and History | TWSE

1795's next earnings is on March 12, 2025 (After Market Close)

When is the earnings report for 1795?

1795 Earnings History

1795's latest dividend is 3.45992 TWD on July 5, 2023

1795 Stock Discussion Forum and Message Board

News for TWSE: 1795